STOCK TITAN

TAO Synergies Announces $11 Million Private Placement

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
private placement

TAO Synergies (Nasdaq: TAOX) announced a $11 million private placement dated October 13, 2025 with existing investors, advisor James Altucher, and new investor DCG. The company will sell 11,000 shares of newly issued Series E convertible preferred stock at a stated value of $1,000 per share, convertible at $8.00 per common share, plus five‑year common stock purchase warrants with an $8.00 exercise price. The offering was made to accredited investors under Section 4(a)(2)/Reg D and is expected to close on or about October 15, 2025, subject to customary closing conditions. The company agreed to file registration statement(s) to cover resale of the unregistered securities.

TAO Synergies (Nasdaq: TAOX) ha annunciato un private placement da 11 milioni di dollari datato 13 ottobre 2025 con investitori esistenti, l'advisor James Altucher e un nuovo investitore DCG. L'azienda venderà 11.000 azioni di nuove azioni privilegiate convertibili di Serie E al valore nominale di 1.000 dollari per azione, convertibili a 8,00 dollari per azione ordinaria, più warrant di acquisto di azioni comuni con scadenza di cinque anni e prezzo di esercizio di 8,00 dollari. L'offerta è stata rivolta a investitori accreditati ai sensi della Sezione 4(a)(2)/Reg D e si prevede che chiuderà intorno al 15 ottobre 2025, soggetta alle consuete condizioni di closing. L'azienda ha concordato di depositare una o più dichiarazioni di registrazione per coprire la rivendita delle securities non registrate.

TAO Synergies (Nasdaq: TAOX) anunció una colocación privada de 11 millones de dólares fechada el 13 de octubre de 2025 con inversores existentes, el asesor James Altucher y un nuevo inversor DCG. La empresa venderá 11,000 acciones de nuevas acciones preferentes convertibles de Serie E con un valor nominal de $1,000 por acción, convertibles a $8.00 por acción común, además de warrants de compra de acciones comunes a cinco años con un precio de ejercicio de $8.00. La oferta se realizó a inversores acreditados conforme a la Sección 4(a)(2)/Reg D y se espera que cierre alrededor del 15 de octubre de 2025, sujeto a las condiciones de cierre habituales. La compañía acordó presentar o preparar declaraciones de registro para cubrir la reventa de los valores no registrados.

TAO Synergies(Nasdaq: TAOX)1100만 달러의 비유동성 배치를 2025년 10월 13일로 확정 발표했고, 기존 투자자들, 고문 James Altucher, 신규 투자자 DCG를 포함합니다. 회사는 11,000주의 신규 발행 E시리즈 전환 가능 우선주를 액면가 $1,000 per share, 주당 $8.00로 전환 가능하게 발행하고, 행사 가격 $8.00의 5년 만기의 보통주 인수 워런트를 제공합니다. 이 공모는 섹션 4(a)(2)/Reg D에 따라 공인 투자자들을 대상으로 하였으며, 일반적으로 마감 조건에 따라 2025년 10월 15일 경에 마감될 예정입니다. 회사는 미등록 증권의 재판매를 커버하기 위한 등록 신청서를 제출하기로 합의했습니다.

TAO Synergies (Nasdaq : TAOX) a annoncé un placement privé de 11 millions de dollars daté du 13 octobre 2025 auprès d'investisseurs existants, du conseiller James Altucher et d'un nouvel investisseur, DCG. La société vendra 11 000 actions de nouvelles actions privilégiées convertibles de série E à une valeur nominale de 1 000 $ par action, convertibles à 8,00 $ par action ordinaire, ainsi que des warrants d'achat d'actions ordinaires d'une durée de cinq ans avec un prix d'exercice de 8,00 $. L'offre a été faite à des investisseurs accédits conformément à la Section 4(a)(2)/Reg D et devrait être clôturée vers le 15 octobre 2025, sous réserve des conditions habituelles de clôture. La société a accepté de déposer des déclarations d'enregistrement pour couvrir la revente des titres non enregistrés.

TAO Synergies (Nasdaq: TAOX) gab eine Private-Placement im Wert von 11 Mio. USD bekannt, datiert auf den 13. Oktober 2025, mit bestehenden Investoren, Berater James Altucher und einem neuen Investor DCG. Das Unternehmen wird 11.000 Aktien neu ausgegebener Serie-E-Umwandlungsvorzugsaktien zu einer Nennwert von 1.000 USD pro Aktie verkaufen, wandelbar zu 8,00 USD pro Stammaktie, plus Fünf-Jahres-Wandelrechte mit einem Ausübungspreis von 8,00 USD. Das Angebot wurde akkreditierten Investoren gemäß Abschnitt 4(a)(2)/Reg D gemacht und soll voraussichtlich am oder um den 15. Oktober 2025 abgeschlossen werden, vorbehaltlich üblicher Abschlussbedingungen. Das Unternehmen hat sich darauf geeinigt, Registrierungsunterlagen vorzulegen, um den Wiederverkauf der nicht registrierten Wertpapiere abzudecken.

TAO Synergies (ناسداك: TAOX) أعلنت عن طرحاً خاصاً بقيمة 11 مليون دولار بتاريخ 13 أكتوبر 2025 مع المستثمرين الحاليين، المستشار جيمس ألتوشر، ومستثمر جديد DCG. ستبيع الشركة 11,000 سهماً من أسهم التفضيل من الفئة E القابلة للتحويل بمبلغ اسمى قدره 1,000 دولار للسهم، قابلة للتحويل عند 8.00 دولار للسهم العادي، بالإضافة إلى مَوارِد شراء أسهم عادية لمدة خمس سنوات بسعر ممارسة قدره 8.00 دولار. تم إجراء العرض للمستثمرين المعتمدين وفق القسم 4(a)(2)/Reg D ومن المتوقع أن يغلق في حوالي 15 أكتوبر 2025، رهن الشروط المعتادة للإغلاق. وافقت الشركة على تقديم بيانات تسجيل لتغطية إعادة بيع الأوراق المالية غير المسجلة.

TAO Synergies (纳斯达克股票代码 TAOX) 宣布了一项金额为 1100万美元 的私募,日期为 2025年10月13日,对象为现有投资者、顾问 James Altucher 以及新投资者 DCG。公司将以面值 每股1,000美元 发行新发行的 E 轮可转换优先股共 11,000 股,可按 每股8.00美元 转换为普通股外,还将提供五年期普通股认股权证,行权价为 8.00 美元。本次发行向符合4(a)(2)/Reg D 规定的合格投资者进行,预计在约 2025年10月15日 完成,需符合通常的交割条件。公司同意提交注册声明以覆盖未注册证券的转售。

Positive
  • $11 million capital raise secured
  • Purchase supported by existing investors and new investor DCG
  • Series E stated value of $1,000 per share
  • Registration rights agreed for resale of unregistered securities
Negative
  • Potential dilution of up to 1,375,000 shares on conversion
  • Additional dilution possible if warrants are exercised

Insights

TAO Synergies secures a $11 million private placement via convertible preferred stock and warrants, led by existing backers and DCG.

The company sold 11,000 shares of Series E convertible preferred stock at a stated value of $1,000 per share, convertible at $8.00 per share, alongside five‑year warrants exercisable at $8.00. The financing was priced above the five‑day trailing average and closed to accredited investors under Section 4(a)(2) and Regulation D.

Completion depends on customary closing conditions and the expected close on or about Oct. 15, 2025. The company agreed to file registration statements under registration rights; until effective, the securities remain unregistered. Watch for the closing confirmation, the SEC registration filing and timing, and any disclosures on dilution from conversion or warrant exercises.

Financing supported by existing stockholders, TAO Strategy Advisor James Altucher, and new investor DCG

NEW YORK, Oct. 13, 2025 /PRNewswire/ -- TAO Synergies Inc. (Nasdaq: TAOX) (the "Company"), a digital asset treasury company focused on Bittensor (TAO), the premier cryptotoken for decentralized artificial intelligence (DeAI), today announced that it has entered into a securities purchase agreement with existing investors, James Altucher and a new investor, DCG, for a $11 million financing.

"TAO Synergies' latest financing further supports its continuing strategic investments not only in TAO tokens, but also in potential opportunities to earn revenue and accrue additional TAO within the Bittensor ecosystem," said James Altucher. "We are pleased to welcome our new strategic investor DCG, a leader in the cryptocurrency and blockchain industry and a major investor and incubator in the Bittensor ecosystem. We have strong conviction in Bittensor's vision for decentralized intelligence and believe its network model will be a key driver of innovation and value creation in the years ahead."

The financing involves the sale of 11,000 shares of the Company's newly issued Series E convertible preferred stock ("preferred stock"), with a stated value of $1,000 per share which is convertible into shares of the Company's common stock, and associated five-year common stock purchase warrants, in a private placement priced above the five-day trailing average price. The shares of Series E preferred stock have a conversion price of $8.00 per share. The warrants have an exercise price of $8.00 per common share.

The transaction is expected to close on or about October 15, 2025, subject to the satisfaction of customary closing conditions.

The securities described above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Act") and Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants sold in the offering, have not been registered under the Act or applicable state securities laws. Accordingly, such securities may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. Pursuant to a registration rights agreement, the Company has agreed to file one or more registration statements with the SEC covering the resale of the unregistered securities to be issued in the offering.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About TAO Synergies

TAO Synergies Inc. is the first pure-play public company focused on the convergence between cryptocurrency and artificial intelligence. The Company's differentiated cryptocurrency treasury strategy is centered exclusively on the acquisition of TAO, the native cryptocurrency of Bittensor, a decentralized blockchain network for machine learning and AI. TAO Synergies Inc. seeks to stake TAO for revenue generation and capital appreciation, a strategy that underscores its mission to create significant value for shareholders. Visit The Tao Daily, a comprehensive media, news, and insight platform dedicated to Bittensor (TAO) and the TAO ecosystem, and taosynergies.com for more information.

Forward-Looking Statements 

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Such forward-looking statements are subject to risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. These and other factors are identified and described in more detail in the Company's filings with the Securities and Exchange Commission. The Company does not undertake to update these forward-looking statements. 

Contact
800-811-5591
ir@taosynergies.com

Cision View original content:https://www.prnewswire.com/news-releases/tao-synergies-announces-11-million-private-placement-302582503.html

SOURCE TAO Synergies Inc.

FAQ

What did TAO Synergies (TAOX) announce on October 13, 2025?

TAO Synergies announced a $11 million private placement selling 11,000 Series E convertible preferred shares and warrants.

When is the TAOX private placement expected to close?

The transaction is expected to close on or about October 15, 2025, subject to customary closing conditions.

What is the conversion and exercise price in the TAOX financing?

The Series E conversion price is $8.00 per common share and the warrants have an $8.00 exercise price.

How many common shares could TAOX issue if all Series E preferred convert?

If fully converted, the Series E could convert into up to 1,375,000 common shares (11,000×$1,000 ÷ $8.00).

Who are the investors participating in TAOX's $11M financing?

The financing is supported by existing stockholders, advisor James Altucher, and new investor DCG.

Will TAO Synergies register the securities sold in the private placement?

Yes; the company agreed to file one or more registration statements to cover resale of the unregistered securities.
TAO Synergies Inc

NASDAQ:TAOX

TAOX Rankings

TAOX Latest News

TAOX Latest SEC Filings

TAOX Stock Data

24.03M
3.40M
2.16%
1.77%
16.35%
Software - Infrastructure
Pharmaceutical Preparations
Link
United States
NEW YORK